Boston Scientific Corporation (BSX)

NYSE: BSX · Real-Time Price · USD

76.28

-0.01 (-0.01%)

At close: Feb 18, 2026, 4:00 PM EST

76.61

+0.33 (0.43%)

After-hours: Feb 18, 2026, 7:59 PM EST

Boston Scientific Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	414	865	928	1,925
Cash & Short-Term Investments	1,275	414	865	928	1,925
Cash Growth	207.97%	-52.14%	-6.79%	-51.79%	11.02%
Accounts Receivable	-	2,558	2,228	1,970	1,778
Receivables	-	2,558	2,228	1,970	1,778
Inventory	-	2,810	2,484	1,867	1,610
Restricted Cash	-	111	130	149	188
Other Current Assets	-	1,027	807	846	816
Total Current Assets	-	6,920	6,514	5,760	6,317
Property, Plant & Equipment	-	3,743	3,298	2,832	2,687
Long-Term Investments	-	556	413	407	411
Goodwill	-	17,089	14,387	12,920	11,988
Other Intangible Assets	-	6,684	6,003	5,969	6,235
Long-Term Deferred Tax Assets	-	3,655	3,841	3,942	4,142
Other Long-Term Assets	-	748	680	639	449
Total Assets	-	39,395	35,136	32,469	32,229
Accounts Payable	-	960	942	862	794
Accrued Expenses	-	2,533	2,136	1,855	1,883
Current Portion of Long-Term Debt	-	1,778	531	20	261
Current Portion of Leases	-	81	76	61	71
Current Income Taxes Payable	-	268	220	232	209
Current Unearned Revenue	-	306	266	220	208
Other Current Liabilities	-	473	762	553	848
Total Current Liabilities	-	6,399	4,933	3,803	4,274
Long-Term Debt	-	8,842	8,566	8,910	8,798
Long-Term Leases	-	527	395	352	395
Long-Term Unearned Revenue	-	329	311	289	276
Long-Term Deferred Tax Liabilities	-	155	134	144	310
Other Long-Term Liabilities	-	1,140	1,267	1,398	1,554
Total Liabilities	-	17,392	15,606	14,896	15,607
Common Stock	-	17	17	17	17
Additional Paid-In Capital	-	21,056	20,647	20,289	19,986
Retained Earnings	-	2,673	819	-750	-1,392
Treasury Stock	-	-2,251	-2,251	-2,251	-2,251
Comprehensive Income & Other	-	275	50	268	262
Total Common Equity	23,394	21,770	19,282	17,573	16,622
Minority Interest	-	233	248	-	-
Shareholders' Equity	23,630	22,003	19,530	17,573	16,622
Total Liabilities & Equity	-	39,395	35,136	32,469	32,229
Total Debt	12,045	11,228	9,568	9,343	9,525
Net Cash (Debt)	-10,770	-10,814	-8,703	-8,415	-7,600
Net Cash Per Share	-7.21	-7.28	-5.95	-5.84	-5.30
Filing Date Shares Outstanding	1,482	1,476	1,467	1,435	1,427
Total Common Shares Outstanding	1,482	1,475	1,466	1,433	1,426
Working Capital	-	521	1,581	1,957	2,043
Book Value Per Share	15.78	14.76	13.16	12.26	11.66
Tangible Book Value	-1,982	-2,003	-1,108	-1,316	-1,601
Tangible Book Value Per Share	-1.34	-1.36	-0.76	-0.92	-1.12
Land	-	144	140	137	109
Buildings	-	2,019	1,843	1,695	1,523
Machinery	-	3,629	3,503	3,298	3,288
Construction In Progress	-	1,035	857	598	605

Updated Feb 4, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q